Skip to main content

Codiak BioSciences, Inc.

CDAKDelisted May 2, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001659352

Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Codiak BioSciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CDAK: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders5162+11
Shares13.4M13.8M+385.3K (+2.9%)
Value$145.4M$86.5M−$58.9M (−40.5%)

New holders (16)

Institutions that held Codiak BioSciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CDAK in Q1 2022
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP101,279$635.0K0.09%
State of Wisconsin Investment Board63,900$401.0K0.00%
Millennium Management LLC36,268$227.0K0.00%
Goldman Sachs Group Inc35,566$223.0K0.00%
Citadel Advisors LLC32,045$201.0K0.00%
Trexquant Investment LP30,068$189.0K0.01%
Forefront Analytics, LLC19,310$122.0K0.05%
Renaissance Technologies LLC18,500$116.0K0.00%
Rhumbline Advisers13,218$83.0K0.00%
Mirabella Financial Services LLP11,500$72.0K0.01%
Denali Advisors LLC6,500$41.0K0.02%
Barclays PLC2,585$17.0K0.00%
Amalgamated Bank2,589$16.0K0.00%
Amalgamated Financial Corp.2,589$16.0K0.00%
Nisa Investment Advisors, LLC1,190$7.00K0.00%
Prospera Financial Services Inc89$1.00K0.00%

Sold out (5)

Institutions that held Codiak BioSciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CDAK in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
UBS Group AG3,722$41.0K
Eaton Vance Management2,000$22.0K
Migdal Insurance & Financial Holdings Ltd.341$4.00K
The PNC Financial Services Group, Inc.200$2.00K
Toth Financial Advisory Corp100$1.00K